icadmed.com (ICAD) - Company Gross Revenue

Corporate emblem and logo of iCAD Corp (ICAD)

Total sales for iCAD, Inc. (ICAD) reflect the dynamics of an AI ecosystem for predictive breast cancer analysis, where 0.02 describes the current status of the metric. Growth is driven by subscriptions and partnerships with medtech giants. High barriers to entry are ensured by patents and FDA approval, which integrate the software into official medical protocols, making it difficult for new players to replicate the technologies.

Revenue and Sales Volume: iCAD Corp (ICAD) for 07/04/2022 - 08/02/2025

Analytical breakdowns for iCAD Inc. (ICAD)

- market price and analyst price targets:
Market Price iCAD Corp|ICAD - Analyst Consensus Forecast
- market capitalization indicators:
Market Capitalization iCAD, Inc.|ICAD - Enterprise Value
- book capitalization data:
Accounting Value per Share iCAD|ICAD - Book Capitalization|Market Capitalization to Book Value Ratio icadmed.com|ICAD - Company Total Assets
- debt and solvency information:
Debt to Equity Ratio iCAD, Inc.|ICAD - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital iCAD Corp|ICAD - Company Aggregate Debts|Debts to Net Assets iCAD, Inc.|ICAD - Company Long-Term Debt|Company Short-Term Indebtedness iCAD|Quick Liquidity Indicator icadmed.com
- company profitability and valuation multiples indicators:
ICAD - Net Income|Company Profit Forecast iCAD, Inc.|ICAD - P/E Multiple|Market Cap to Projected Earnings iCAD Corp|ICAD - PEG Multiple|Enterprise Value to EBITDA Ratio iCAD, Inc.|ICAD - Operating profit EBITDA|Net earnings per share (EPS TTM) iCAD|ICAD - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last 12 months icadmed.com|ICAD - Earnings growth in current year|Expected earnings per share growth for next year iCAD, Inc.
- company sales and revenue statistics:
ICAD - Revenue and Sales Volume|Projected Sales Volume iCAD Corp|ICAD - Price-to-Revenue Ratio|Market Cap to Projected Revenue iCAD, Inc.
Summary company analysis:iCAD, Inc.
Product sample of iCAD, Inc.

Steady revenue growth confirms the fundamental stability of iCAD, Inc. (ICAD), while the company's sales performance is based on daily monitoring of operational liquidity to accurately calculate the control premium. This metric reflects the scaling efficiency of B2B subscriptions for ProFound AI platforms, allowing investors to assess the pace of software expansion across radiology centers and the capture of market share.

Analysis of competing companies

Company Total Revenue BeiGene Oncology ONC|Revenue and Sales Volume HALO|Company Gross Revenue revmed.com|Revenue and Sales Volume AAPG (Ascentage Pharma)|CGON - Company Sales|UroGen - Revenue and Sales Volume|BCAX - Revenue and Sales Volume|PSNL: Revenue and Sales Volume|Company Sales Volume ERAS|Company Sales DCTH|YMAB: Company Sales Revenue|Revenue and Sales Volume AURA|Company Gross Revenue candeltx.com|Company Revenue Accuray Incorporated ARAY|SLS: Company Sales Volume|Actuate Therapeutics - Revenue and Sales Volume|Citius Oncology Inc. (CTOR) - Company Sales|HURA (tuhurabio.com) - Company Sales|TARA - Company Gross Revenue|FATE (Fate Therapeutics, Inc.) - Revenue and Sales Volume|Aadi Bio (WHWK) - Company Gross Revenue|Revenue and Sales Volume TCRX|Company Sales championsoncology.com CSBR|Revenue and Sales Volume XBIT (XBiotech)|Revenue and Sales Volume CEL-SCI Corp. CVM|OS Therapies Incorporated - Revenue and Sales Volume|RADX (Radiopharm Theranostics Ltd) - Company Sales Volume|ARTV: Revenue and Sales Volume|Company Sales Adlai Nortye|VERU (Veru Pharma) - Revenue and Sales Volume|Revenue and Sales Volume Tempest Therapeutics Corp|Company Revenue Xilio Therapeutics, Inc. (XLO)|renovarobio.com - Company Sales Volume|Revenue and Sales Volume MURA (Mural Oncology)|KAPA - Company Sales|OnKure - Revenue and Sales Volume|Company Total Revenue CytoMed Therapeutics|curis.com (CRIS) - Company Revenue|Apollomics - Company Sales Revenue|Company Sales THAR|ADVB: Company Sales Revenue|Revenue and Sales Volume GNPX|Company Sales calidibio.com CLDI|Sunshine Biopharma - Company Sales|Revenue and Sales Volume Xenetic Biosciences Inc. XBIO|SLRX - Company Revenue|Company Sales Revenue PPBT (Purple Biotech Ltd)|AONC: Revenue and Sales Volume|Company Total Revenue BeiGene Ltd (BGNE)|CKPT (Checkpoint Therapeutics) - Revenue and Sales Volume|Elevation Oncology Inc. (ELEV) - Company Gross Revenue|Revenue and Sales Volume IKNA|Company Sales Notable Labs Ltd NTBL|Revenue and Sales Volume VIRX (Viracta Therapeutics, Inc.)|Revenue and Sales Volume MorphoSys Corporation MOR|NAYA Biosciences - Revenue and Sales Volume|AAPGV (ascentage.com) - Company Sales Volume